Skip to main content

Table 1 Subject baseline characteristics and demographics

From: The Effect of Food on the Absorption of Abiraterone Acetate from a Fine Particle Dosage Form: A Randomized Crossover Trial in Healthy Volunteers

  Sequence AB
n = 12
Sequence BA
n = 13
All subjects treated
N = 25
All subjects completed
n = 22a
Baseline characteristics     
 Age (years)     
  Mean 38.0 35.2 36.5 36.3
  SD 8.7 9.4 9.0 9.1
 Height (cm)     
  Mean 183.2 176.0 179.4 178.6
  SD 4.5 4.6 5.8 5.0
 Weight (kg)     
  Mean 89.4 78.9 83.9 82.2
  SD 12.5 8.4 11.7 10.6
 BMI (kg/m2)
  Mean 26.6 25.5 26.0 25.8
  SD 3.3 2.6 2.9 3.0
Demographics
 Ethnicity
  Hispanic/Latino 1 (8.3%) 3 (23.1%) 4 (16.0%) 4 (18.2%)
  Not Hispanic or Latino 11 (91.7%) 10 (76.9%) 21 (84.0%) 18 (81.8%)
 Race
  White 3 (25.0%) 7 (53.8%) 10 (40.0%) 8 (36.4%)
  Black/African American 9 (75.0%) 5 (38.5%) 14 (56.0%) 13 (59.1%)
  Asian 0 (0.0%) 1 (7.7%) 1 (4.0%) 1 (4.5%)
  1. Treatment A: AAFP 500 mg under fed conditions
  2. Treatment B: AAFP 500 mg under fasted conditions
  3. AAFP abiraterone acetate fine particle, BMI body mass index, SD standard deviation
  4. aTwo subjects were discontinued; one for violation of house rules and one for pre-existing increased blood pressure. One subject was lost to follow-up